A Study to Evaluate Safety and Effectiveness of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan (SELECT AXIS RW)
Status: Recruiting
Location: See all (58) locations...
Study Type: Observational
SUMMARY
Axial spondyloarthritis (axSpA), which encompasses radiographic axSpA (r-axSpA, also known as ankylosing spondylitis \[AS\]) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. This study will assess how effective Rinvoq is in treating axSpA. Rinvoq is an approved drug for treating axSpA. Approximately 100 adult participants who are prescribed Rinvoq by their physician in accordance with local label will be enrolled in Japan. Participants will receive Rinvoq as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 52 weeks. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Participant with clinical diagnosis of ankylosing spondylitis (AS) and meeting the modified New York Criteria for AS.
• Participant who is administered the first dose of Rinvoq for AS.
Locations
Other Locations
Japan
Anan Medical Center /ID# 268818
RECRUITING
Anan-shi
Nishiogu Clinic /ID# 266670
RECRUITING
Arakawa City
National Hospital Organization Asahikawa Medical Center /ID# 268282
RECRUITING
Asahikawa
Katayama Orthopedic Rheumatology Clinic /ID# 251071
RECRUITING
Asahikawa-shi
Juntendo University Hospital /ID# 251103
RECRUITING
Bunkyo-ku
Tokyo Medical And Dental University Hospital /ID# 252569
RECRUITING
Bunkyo-ku
Suzuki Clinic Orthopaedics River City /ID# 254482
RECRUITING
Chuo-ku
Kasugai Clinic /ID# 253201
RECRUITING
Fuefuki-shi
Yagi Hospital /ID# 251078
RECRUITING
Fukuoka
Himeji Medical Center /ID# 255197
RECRUITING
Himeji-shi
Chiyoda Hospital /ID# 251077
RECRUITING
Hyuga-shi
Kagoshima University Hospital /ID# 256997
RECRUITING
Kagoshima
Kanazawa University Hospital /ID# 252170
RECRUITING
Kanazawa
Tomita Clinic /ID# 251075
RECRUITING
Kashiwa-shi
Kurotsuchi Orthopaedic Clinic /ID# 251076
RECRUITING
Kasugashi
National Hospital Organization Osaka Minami Medical Center /ID# 251072
RECRUITING
Kawachinagano Shi
Takahashi Clinic /ID# 252924
RECRUITING
Kawasaki-shi
Toranomon Hospital Kajigaya /ID# 260158
RECRUITING
Kawasaki-shi
Hospital of the University of Occupational and Environmental Health, Japan /ID# 252570
RECRUITING
Kitakyushu-shi
Kunou Orthopedic Clinic /ID# 252168
RECRUITING
Kitakyushu-shi
Kobe Kaisei Hospital /ID# 251073
RECRUITING
Kobe
Kyoto Okamoto Memorial Hospital /ID# 255153
RECRUITING
Kuse District
Kyoto University Hospital /ID# 261970
RECRUITING
Kyoto
Matsuyama Red Cross Hospital /ID# 261974
RECRUITING
Matsuyama
Yamada Rheumatology Clinic /ID# 264182
RECRUITING
Matsuyama
National Hospital Organization Tokyo Medical Center /ID# 270441
RECRUITING
Meguro City
Clinic Quest For Rheumatology & Well-being /ID# 268817
RECRUITING
Mito
National Hospital Organization Miyakonojo Medical Center /ID# 268280
RECRUITING
Miyakonojō
University of Miyazaki Hospital /ID# 266669
RECRUITING
Miyazaki
Japan Organization of Occupational Health and Safety Chubu Rosai Hospital /ID# 258201
RECRUITING
Nagoya
Nagoya University Hospital /ID# 254435
RECRUITING
Nagoya
500koku Orthopedic Clinic /ID# 268283
RECRUITING
Nakaniikawa-gun
Hyogo Medical University Hospital /ID# 253200
RECRUITING
Nishinomiya-shi
Nagasaki Kita Hospital /ID# 266672
RECRUITING
Nishisonogi-gun
Noda Hospital /ID# 254429
RECRUITING
Noda-shi
Oribe Clinic of Rheumatism and Medicine /ID# 251079
RECRUITING
Ōita
Kinshukai Infusion Clinic /ID# 251070
RECRUITING
Osaka
Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 252166
RECRUITING
Osaka
Osaka City General Hospital /ID# 258202
RECRUITING
Osaka
Osaka Metropolitan University Hospital /ID# 254436
RECRUITING
Osaka
Kitasato University Hospital /ID# 254480
RECRUITING
Sagamihara-shi
Yoshida Internal Medicine Clinic - Sakaki /ID# 268285
RECRUITING
Sakaki
Sanuki Municipal Hospital /ID# 251104
RECRUITING
Sanuki-shi
Hokkaido University Hospital /ID# 258203
RECRUITING
Sapporo
Sapporo Rheumatology and immunology clinic /ID# 256175
RECRUITING
Sapporo
Sasebo Chuo Hospital /ID# 253202
RECRUITING
Sasebo-shi
Meiyo Immunology & Rheumatology Clinic /ID# 256176
RECRUITING
Suginami -ku
Takaoka Rheumatic Orthopedic Clinic /ID# 252895
RECRUITING
Takaoka-shi
Inoue Hospital /ID# 261959
RECRUITING
Takasaki-shi
Osaka Medical and Pharmaceutical University Hospital /ID# 260159
RECRUITING
Takatsuki-shi
Tenri Hospital /ID# 256996
RECRUITING
Tenri-shi
Toyama Hospital /ID# 268281
RECRUITING
Toyama
Toyama University Hospital /ID# 251682
RECRUITING
Toyama
Fujita Health University Hospital /ID# 258204
RECRUITING
Toyoake
Koga Community Hospital /ID# 251074
RECRUITING
Yaizu
Sakuragicho Yokohama Clinic /ID# 266671
RECRUITING
Yokohama
Yokohama City University Medical Center /ID# 258149
RECRUITING
Yokohama
Yokohama Minami Kyousai Hosp /ID# 252172
RECRUITING
Yokohama
Contact Information
Primary
AbbVie GK Clinical Trial Registration Desk
abbvie_jpn_info_clingov@abbvie.com
+81-3-4577-1111
Time Frame
Start Date: 2022-07-06
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 100
Treatments
Rinvoq
Participants will receive Rinvoq as prescribed by their physician according to local label.
Related Therapeutic Areas
Sponsors
Leads: AbbVie